Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

NIH 1INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Dermatologic 1

Conditions

Squamous Cell Carcinoma of Head and Neck 1Skin Neoplasms 1Sarcoma, Kaposi 1Melanoma 1HIV Infections 1Adenoviridae Infections 1Acquired Immunodeficiency Syndrome 1

Interventions

Doxorubicin 5tecogalan 4Liposomes 4Vincristine 3Bleomycin 3Semaxinib 2Mitoxantrone 2Alitretinoin 2ziconotide 1vesnarinone 1tin etiopurpurin 1technetium-diethylenetriaminepentaacetic acid-mannosyl-dextran 1Zidovudine 1Tumor Necrosis Factor-alpha 1Sugars 1Ro 24-7429 1Ritonavir 1Paclitaxel 1Nelfinavir 1Mitoguazone 1Maltose 1Interferon-alpha 1Inosine Pranobex 1Fluconazole 1Etoposide 1Daunorubicin 1Dapsone 1Cidofovir 1Bexarotene 1Amphotericin B 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
INDUSTRY × HIV Infections × Tumor Necrosis Factor-alpha × Clear all
NCT00002262 2005-06-24

A Phase I/II Study of Intralesional Recombinant Tumor Necrosis Factor in Patients With AIDS-Related Cutaneous Kaposi's Sarcoma

NIH AIDS Clinical Trials Information Service

Phase 1 Completed
DermatologicSarcoma

Acquired Immunodeficiency Syndrome, Sarcoma, Kaposi, Skin Neoplasms, HIV Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡